Live from the NIH registry
Studies recruiting near Champaign right now
Top 25 of 176 recruiting studies, sorted by proximity — each links to its official registry page
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: SWOG Cancer Research Network
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Cancer
N/A
Interventional 500 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Eastern Cooperative Oncology Group
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Champaign, IL — Champaign, Illinois (1.6 mi)
· Sponsor: Mediar Therapeutics
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Carle Health — Urbana, Illinois (3.5 mi)
· Sponsor: Paradigm Health
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Gilead Sciences
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Non-Invasive Neurofeedback Training to Alleviate Tinnitus Distress
Tinnitus Aggravated, Tinnitus
N/A
Interventional 20 participants sought
Beckman Institute Biomedical Imaging Centre — Urbana, Illinois (3.5 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Breast Neoplasms, Brain Neoplasms
Phase 1, Phase 2
Interventional 73 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Stemline Therapeutics, Inc.
Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
Spinal Cord Injuries (SCI), Multiple Sclerosis
N/A
Interventional 120 participants sought
Disability Participation and Quality of Life (DPQOL) Laboratory — Urbana, Illinois (3.5 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Alcohol, Breast Cancer, and Metabolism
Alcohol Drinking, Ethanol Intoxication
N/A
Interventional 50 participants sought
Bevier Hall; University of Illinois at Urbana Champaign — Urbana, Illinois (3.5 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: SWOG Cancer Research Network
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast Cancer, Locally Advanced Breast Cancer
Phase 3
Interventional 1,000 participants sought
Clinical Trial Site — Urbana, Illinois (3.5 mi)
· Sponsor: Olema Pharmaceuticals, Inc.
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Carle Foundation Cancer Institute-Urbana — Urbana, Illinois (3.5 mi)
· Sponsor: BriaCell Therapeutics Corporation
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 165 participants sought
Christie Clinic on University /ID# 277871 — Champaign, Illinois (1.6 mi)
· Sponsor: AbbVie
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Obesity or Overweight, Weight-Related Comorbidity
Phase 3
Interventional 500 participants sought
Research Site — Champaign, Illinois (1.6 mi)
· Sponsor: AstraZeneca
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Urbana, Illinois (3.5 mi)
· Sponsor: TG Therapeutics, Inc.
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)